The Tim and Caroline Reynolds Center for Spinal Stimulation at Kessler Foundation has become the first medical center in New ...

An allogeneic stem cell-derived transplant, OPC1 helps restore or increase the functional activity in SCI patients. It is tailored to replace the spinal cord cells that are either ...

More than 15 million people worldwide are living with spinal cord injury (SCI), which can affect their sensory and motor ...

Her injuries have left her with paralysis in her right leg, weakness in her left leg and some degree of paralysis in both ...

It's a piano riff that fires off an anthem we all know by heart. "I Will Survive" is a disco masterpiece by two-time Grammy ...

Neurosurgeon Jocelyne Bloch, MD, and neuroscientist Grégoire Courtine, PhD, co-direct their lab, NeuroRestore, and are working to use artificial intelligence-driven implants to help spinal cord injury ...

Neuvotion announced today that it received FDA 510(k) clearance for its first product, the NeuStim wearable device.

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

Neuvotion has received FDA 510(k) clearance for their first product, NeuStim™, a non-invasive, surgery-free wearable that ...

February 11, 2025) - Philadelphia-based catastrophic injury lawyers, The Weitz Firm, LLC, expands focus on complex medical and personal injury litigation. As a premier law firm based in Philadelphia, ...

Lineage Cell Therapeutics (LCTX) announced that the Company has initiated the DOSED clinical study. The DOSED study will evaluate the safety ...